Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Effective acne management in PCOS includes hormone therapy, metformin, isotretinoin, weight loss, diet, exercise, and personalized treatment plans.

Hormonal imbalances are a key cause of missed menstrual periods in women.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

El Síndrome de Ovario Poliquístico causa problemas de piel como acné y es importante reconocerlo temprano para tratarlo.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Lupus can cause hair loss and nail changes, with treatments available for both.

Various treatments exist for hair loss, but more research is needed for better options.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.